Answers are grounded in this paper and cite their sources.
The aim of this work was to evaluate the effects of incorporating thrombin in arabinogalactan (AG)/β-glucan (BG)-based carriers. The products were characterized by Fourier transform infrared spectroscopy, scanning electron microscopy, X-ray powder diffraction (XRPD) and X-ray photoelectron spectroscopy techniques. Results, especially deconvoluted XRPD patterns indicated creation of new phases and potential complex formation. Results also highlighted that the AG carrier leads to higher residual thrombin-specific activity, while the in vivo haemostatic effect was enhanced when insoluble BG was present in the matrix. Our results confirm that thrombin can be successfully added to the carriers and that these materials are promising alternatives to standard vehicles.
No takes yet. Share an insight, caveat, or question.
Veverka et al. (2015) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: